Login / Signup

Comparison of Efficacy and Safety between Long-Acting Injectable Antipsychotic Monotherapy and Combination of Long-Acting Injectable and Oral Antipsychotics in Patients with Schizophrenia.

Thanompong SathienluckanaPornyupa TiangpattanawongKarnpreena ChaiyasukthananoanPannapat JittayananHathaipat SawetwangsingPunyawee Puchsaka
Published in: Schizophrenia research and treatment (2021)
The efficacy and safety of LAI antipsychotic monotherapy appeared similar to the combination of LAI and oral antipsychotics in patients with schizophrenia. Therefore, the combination of LAI and oral antipsychotics, which is commonly used in clinical practice, may not be necessary.
Keyphrases
  • clinical practice
  • combination therapy
  • open label
  • hyaluronic acid
  • clinical trial
  • randomized controlled trial